1. Home
  2. NKTR vs NXDT Comparison

NKTR vs NXDT Comparison

Compare NKTR & NXDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • NXDT
  • Stock Information
  • Founded
  • NKTR 1990
  • NXDT 2012
  • Country
  • NKTR United States
  • NXDT United States
  • Employees
  • NKTR N/A
  • NXDT N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • NXDT Investment Managers
  • Sector
  • NKTR Health Care
  • NXDT Finance
  • Exchange
  • NKTR Nasdaq
  • NXDT Nasdaq
  • Market Cap
  • NKTR 160.4M
  • NXDT 156.8M
  • IPO Year
  • NKTR 1994
  • NXDT N/A
  • Fundamental
  • Price
  • NKTR $0.59
  • NXDT $3.38
  • Analyst Decision
  • NKTR Strong Buy
  • NXDT
  • Analyst Count
  • NKTR 6
  • NXDT 0
  • Target Price
  • NKTR $4.92
  • NXDT N/A
  • AVG Volume (30 Days)
  • NKTR 2.3M
  • NXDT 133.6K
  • Earning Date
  • NKTR 05-08-2025
  • NXDT 01-01-0001
  • Dividend Yield
  • NKTR N/A
  • NXDT 9.66%
  • EPS Growth
  • NKTR N/A
  • NXDT N/A
  • EPS
  • NKTR N/A
  • NXDT 0.99
  • Revenue
  • NKTR $87,248,000.00
  • NXDT N/A
  • Revenue This Year
  • NKTR N/A
  • NXDT N/A
  • Revenue Next Year
  • NKTR N/A
  • NXDT N/A
  • P/E Ratio
  • NKTR N/A
  • NXDT $6.41
  • Revenue Growth
  • NKTR N/A
  • NXDT N/A
  • 52 Week Low
  • NKTR $0.43
  • NXDT $5.89
  • 52 Week High
  • NKTR $1.93
  • NXDT $13.07
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 39.04
  • NXDT 37.56
  • Support Level
  • NKTR $0.57
  • NXDT $3.41
  • Resistance Level
  • NKTR $0.81
  • NXDT $3.70
  • Average True Range (ATR)
  • NKTR 0.06
  • NXDT 0.16
  • MACD
  • NKTR -0.01
  • NXDT 0.01
  • Stochastic Oscillator
  • NKTR 7.48
  • NXDT 16.39

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About NXDT NexPoint Diversified Real Estate Trust

NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. The revenue sources of the company include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates through its operating partnership and wholly owned subsidiaries.

Share on Social Networks: